Préparation de Mary récupération
Food supplement declared in France, declaration No 2021-12-171, decision dated 5 December 2021
Préparation de Mary récupération is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- not provided
- Food business operator placing the product on the market
- PERFECT HEALTH SOLUTIONS
- Status
- Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
- Form
- Sachet
- Daily dose
- 1 sachet au besoin, après un effort
- Directions for use
- Diluer la poudre contenue dans un sachet, au besoin, après un effort, dans 200,00 ml d'eau chaude.
- Not recommended for (according to the manufacturer)
- Femmes allaitantes, Femmes enceintes
- Objectives stated by the manufacturer (these are not authorised claims)
- Sport
- Flavourings
- tomate
Declaration 304280, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
None of the rules we check applies to the declared ingredients.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Solanum lycopersicum L. | Fruit | Poudre (de plantes séchées ou broyées) | 900 mg |
| Zingiber officinale Roscoe | Rhizome | Poudre (de plantes séchées ou broyées) | 500 mg |
| Piper longum L. | Fruit | Poudre (de plantes séchées ou broyées) | 460 mg |
| Brassica napus L. | Graine | Pression à froid | 450 mg |
| Petroselinum crispum (Mill.) Fuss | Parties aériennes | Poudre (de plantes séchées ou broyées) | 250 mg |
| Capsicum annuum L. | Fruit | Extrait sec aqueux | 100 mg |
| Paullinia cupana Kunth | Graine | Poudre (de plantes séchées ou broyées) | 50 mg |
Other active ingredients
| Name | Per day |
|---|---|
| Hydrolysat de protéines | not declared |
Micro-organisms
| Strain | Per day |
|---|---|
| cerevisiae boulardii Saccharomyces Hansen CB5 5926 | 30,400,000,000 (unit not declared) |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| Acide nicotinique | Acide nicotinique (vitamine B3) | 10 mg | 8 mg |
| D-pantothénate de sodium | Acide pantothénique (vitamine B5) | pas de limite (données insuffisantes) | dose annulée par le Conseil d'État en 2011 |
| D-biotine | Biotine (vitamine B8) | pas de limite (données insuffisantes) | dose annulée par le Conseil d'État en 2011 |
| Chlorure de calcium | Calcium | 2,500 mg | 800 mg |
| Acide ptéroylmonoglutamique | Folates (vitamine B9) | 1,000 µg | 200 µg |
| Sels de magnésium de l'acide citrique | Magnésium | 250 mg | 300 mg |
| Chlorure de potassium | Potassium | pas de limite (données insuffisantes) | 80 mg |
| Chlorure de sodium | Sodium | pas de limite (données insuffisantes) | aucune dose fixée |
| Chlorhydrate de thiamine | Vitamine B1 (thiamine) | pas de limite (données insuffisantes) | dose annulée par le Conseil d'État en 2011 |
| Méthylcobalamine | Vitamine B12 | pas d'effet indésirable défini | dose annulée par le Conseil d'État en 2011 |
| Chlorhydrate de pyridoxine | Vitamine B6 | 12 mg | 2 mg |
Other ingredients
saccharose
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Label warnings
La mise en garde est due à la présence d'acide nicotinique dans notre formule.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Zingiber officinale Roscoe
Read the warning, when it applies and the studies cited
GINGER - ZINGIBER OFFICINALE
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
- Capsicum annuum L.
Read the warning, when it applies and the studies cited
CAYENNE - CAPSICUM ANNUUM Oral
Cautions and warnings
Condition of application: All products.
Keep out of the reach of children. If overdose or accidental ingestion occurs, call a poison control centre or get medical help right away (CPS 2008).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Bradley 2006; Boon and Smith 2004).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have stomach ulcers or inflammation (Brinker 2010).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: Digestion; Peripheral circulation.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Health Canada monograph dated 27 March 2026
CAYENNE - CAPSICUM ANNUUM/CAPSAICIN Topical
Cautions and warnings
Condition of application: All products.
For external use only (US FDA 2023).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
When using this product avoid contact with the eyes and mucous membranes. If contact occurs, rinse thoroughly with water (US FDA 2023).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist, worsen, or re-occur within a few days (US FDA 2023).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Keep out of the reach of children. If swallowed, call a poison control centre or get medical help right away (CPS 2008).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Condition of application: All products.
Stop use if headache, redness, rashes, burning discomfort and/or hypersensitivity occur (Brayfield and Cadart 2024; Zhang et al. 2008; Hoffman 2003; APhA 2002; McCleane 2000).
5 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.